Patenting of therapeutic antibodies – An update on US and EPO practice
Antibodies constitute a very important class of drugs and diagnostic tools. A lot has happened since the early days of isolating antibodies from serum or from hybridoma. Today sophisticated methods are used in antibody discovery and these methods lead with great likelihood to identification of an antibody lead. These advances in antibody discovery have made it more challenging to obtain patent protection for new antibodies in some countries. Experts from HOIBERG will give some practical guidance on issues to consider in antibody discovery to maximise the chances of being able to obtain patent protection. Read more at;

After the presentation it is possible to book a 20 minutes private time-slot with HØIBERG´s patent experts – contact to reserve your slot

Presenter: Jens Viktor Nørgaard, HØIBERG
Date:   March 19, 2021
Time:   13:00-13:45
Venue: Zoom 
Where to register